CME Group (NASDAQ:CME) had its price objective hoisted by Deutsche Bank from $185.00 to $197.00 in a research note published on Friday. The brokerage currently has a buy rating on the financial services provider’s stock.
Several other research firms also recently issued reports on CME. ValuEngine downgraded shares of CME Group from a buy rating to a hold rating in a report on Wednesday, March 7th. Zacks Investment Research cut shares of CME Group from a buy rating to a hold rating in a research note on Tuesday, March 6th. Bank of America upped their target price on shares of CME Group from $175.00 to $185.00 and gave the company a buy rating in a research note on Thursday, March 8th. BidaskClub cut shares of CME Group from a strong-buy rating to a buy rating in a research note on Thursday, March 15th. Finally, Barclays upped their target price on shares of CME Group from $170.00 to $175.00 and gave the company an overweight rating in a research note on Friday, February 2nd. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of Buy and a consensus target price of $163.69.
NASDAQ CME opened at $158.26 on Friday. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.10. The firm has a market cap of $53,869.33, a P/E ratio of 33.25, a PEG ratio of 2.19 and a beta of 0.56. CME Group has a 1 year low of $114.82 and a 1 year high of $171.71.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.02. The business had revenue of $900.00 million during the quarter, compared to the consensus estimate of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. CME Group’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.14 EPS. equities research analysts expect that CME Group will post 6.89 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were paid a $0.70 dividend. This is a boost from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.77%. CME Group’s dividend payout ratio is currently 58.70%.
In other news, Chairman Terrence A. Duffy sold 20,000 shares of the stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total value of $3,033,200.00. Following the completion of the transaction, the chairman now owns 99,239 shares in the company, valued at approximately $15,050,586.74. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO John W. Pietrowicz sold 7,500 shares of the stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the completion of the transaction, the chief financial officer now owns 32,376 shares of the company’s stock, valued at approximately $4,904,964. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,699 shares of company stock valued at $6,266,062. Corporate insiders own 0.45% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. ARK Investment Management LLC acquired a new stake in shares of CME Group during the 4th quarter worth about $120,000. Valeo Financial Advisors LLC acquired a new stake in shares of CME Group during the 3rd quarter worth about $124,000. AlphaOne Investment Services LLC acquired a new stake in shares of CME Group during the 4th quarter worth about $146,000. Mosaic Family Wealth LLC acquired a new stake in shares of CME Group during the 4th quarter worth about $146,000. Finally, Truewealth LLC acquired a new stake in shares of CME Group during the 4th quarter worth about $157,000. Institutional investors and hedge funds own 83.12% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/04/09/deutsche-bank-raises-cme-group-cme-price-target-to-197-00.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.